Total Payments
$419,550
2024 Payments
$69,631
Companies
34
Transactions
702
Medicare Patients
838
Medicare Billing
$145,117
Payment Breakdown by Category
Other$340,693 (81.2%)
Travel$43,602 (10.4%)
Food & Beverage$17,495 (4.2%)
Consulting$16,325 (3.9%)
Research$1,297 (0.3%)
Education$137.82 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Honoraria | $253,575 | 86 | 60.4% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $64,118 | 43 | 15.3% |
| Travel and Lodging | $43,602 | 163 | 10.4% |
| Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program | $23,000 | 17 | 5.5% |
| Food and Beverage | $17,495 | 370 | 4.2% |
| Consulting Fee | $16,325 | 9 | 3.9% |
| Unspecified | $1,297 | 10 | 0.3% |
| Education | $137.82 | 4 | 0.0% |
Payments by Type
General
$418,253
692 transactions
Research
$1,297
10 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| SK Life Science, Inc. | $281,070 | 263 | $0 (2024) |
| LivaNova USA, Inc. | $38,531 | 87 | $0 (2023) |
| UCB, Inc. | $38,163 | 104 | $0 (2024) |
| EISAI INC. | $27,017 | 56 | $0 (2019) |
| Lundbeck LLC | $16,173 | 53 | $0 (2018) |
| UCB Biosciences Inc. | $6,125 | 2 | $0 (2017) |
| AQUESTIVE THERAPEUTICS, INC. | $4,228 | 7 | $0 (2020) |
| Cyberonics, Inc. | $1,745 | 6 | $0 (2017) |
| UCB SA | $1,492 | 9 | $0 (2018) |
| Biogen, Inc. | $1,297 | 10 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $69,631 | 58 | SK Life Science, Inc. ($68,501) |
| 2023 | $79,789 | 92 | SK Life Science, Inc. ($79,069) |
| 2022 | $99,959 | 92 | SK Life Science, Inc. ($99,536) |
| 2021 | $26,679 | 36 | SK Life Science, Inc. ($22,300) |
| 2020 | $21,846 | 41 | SK Life Science, Inc. ($11,664) |
| 2019 | $22,086 | 88 | LivaNova USA, Inc. ($8,545) |
| 2018 | $53,682 | 142 | LivaNova USA, Inc. ($22,952) |
| 2017 | $45,878 | 153 | Eisai Inc. ($15,977) |
All Payment Transactions
702 individual payment records from CMS Open Payments — Page 1 of 29
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | SK Life Science, Inc. | — | Food and Beverage | In-kind items and services | $103.60 | General |
| 12/08/2024 | UCB, Inc. | — | Food and Beverage | In-kind items and services | $199.67 | General |
| 11/06/2024 | Neurelis, Inc. | VALTOCO (Drug) | Food and Beverage | In-kind items and services | $41.66 | General |
| Category: EPILEPSY | ||||||
| 09/20/2024 | SK Life Science, Inc. | XCOPRI (Drug) | Consulting Fee | Cash or cash equivalent | $1,400.00 | General |
| Category: Neurology | ||||||
| 09/14/2024 | NEUROPACE, INC. | RNS Neurostimulator Kit (Device) | Food and Beverage | In-kind items and services | $623.04 | General |
| Category: Epilepsy | ||||||
| 09/06/2024 | SK Life Science, Inc. | XCOPRI (Drug) | Honoraria | Cash or cash equivalent | $3,500.00 | General |
| Category: Neurology | ||||||
| 09/06/2024 | SK Life Science, Inc. | XCOPRI (Drug) | Travel and Lodging | Cash or cash equivalent | $148.46 | General |
| Category: Neurology | ||||||
| 09/06/2024 | SK Life Science, Inc. | XCOPRI (Drug) | Food and Beverage | In-kind items and services | $100.23 | General |
| Category: Neurology | ||||||
| 09/03/2024 | SK Life Science, Inc. | XCOPRI (Drug) | Honoraria | Cash or cash equivalent | $2,100.00 | General |
| Category: Neurology | ||||||
| 08/05/2024 | SK Life Science, Inc. | — | Food and Beverage | In-kind items and services | $154.50 | General |
| 08/05/2024 | SK Life Science, Inc. | — | Food and Beverage | In-kind items and services | $48.38 | General |
| 07/30/2024 | SK Life Science, Inc. | XCOPRI (Drug) | Honoraria | Cash or cash equivalent | $4,200.00 | General |
| Category: Neurology | ||||||
| 07/30/2024 | SK Life Science, Inc. | XCOPRI (Drug) | Travel and Lodging | Cash or cash equivalent | $458.70 | General |
| Category: Neurology | ||||||
| 07/30/2024 | SK Life Science, Inc. | XCOPRI (Drug) | Travel and Lodging | In-kind items and services | $236.95 | General |
| Category: Neurology | ||||||
| 07/30/2024 | SK Life Science, Inc. | XCOPRI (Drug) | Food and Beverage | In-kind items and services | $105.55 | General |
| Category: Neurology | ||||||
| 07/23/2024 | SK Life Science, Inc. | XCOPRI (Drug) | Honoraria | Cash or cash equivalent | $3,500.00 | General |
| Category: Neurology | ||||||
| 07/23/2024 | SK Life Science, Inc. | XCOPRI (Drug) | Food and Beverage | In-kind items and services | $108.39 | General |
| Category: Neurology | ||||||
| 07/23/2024 | SK Life Science, Inc. | XCOPRI (Drug) | Travel and Lodging | Cash or cash equivalent | $93.80 | General |
| Category: Neurology | ||||||
| 07/16/2024 | SK Life Science, Inc. | XCOPRI (Drug) | Honoraria | Cash or cash equivalent | $3,500.00 | General |
| Category: Neurology | ||||||
| 07/16/2024 | SK Life Science, Inc. | XCOPRI (Drug) | Food and Beverage | In-kind items and services | $117.99 | General |
| Category: Neurology | ||||||
| 07/16/2024 | SK Life Science, Inc. | XCOPRI (Drug) | Travel and Lodging | Cash or cash equivalent | $91.29 | General |
| Category: Neurology | ||||||
| 07/02/2024 | SK Life Science, Inc. | XCOPRI (Drug) | Honoraria | Cash or cash equivalent | $3,500.00 | General |
| Category: Neurology | ||||||
| 07/02/2024 | SK Life Science, Inc. | XCOPRI (Drug) | Food and Beverage | In-kind items and services | $178.74 | General |
| Category: Neurology | ||||||
| 06/20/2024 | SK Life Science, Inc. | XCOPRI (Drug) | Honoraria | Cash or cash equivalent | $4,900.00 | General |
| Category: Neurology | ||||||
| 06/20/2024 | SK Life Science, Inc. | XCOPRI (Drug) | Travel and Lodging | In-kind items and services | $331.21 | General |
| Category: Neurology | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| Phase 2 Efficacy, Safety, and Tolerability Study of Natalizumab in Focal Epilepsy | Biogen, Inc. | $1,297 | 10 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 179 | 279 | $157,083 | $35,458 |
| 2022 | 5 | 156 | 262 | $127,746 | $30,562 |
| 2021 | 7 | 257 | 360 | $163,923 | $40,045 |
| 2020 | 7 | 246 | 337 | $175,962 | $39,052 |
Total Patients
838
Total Services
1,238
Medicare Billing
$145,117
Procedure Codes
25
All Medicare Procedures & Services
25 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 95720 | Measurement of brain wave activity with video (veeg), 12-26 hours with review and report by health care professional | Facility | 2023 | 50 | 96 | $87,648 | $17,880 | 20.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 59 | 111 | $40,404 | $12,144 | 30.1% |
| 95718 | Measurement of brain wave activity with video (veeg), 2-12 hours with review and report by health care professional | Facility | 2023 | 19 | 19 | $11,210 | $2,248 | 20.1% |
| 95717 | Measurement of brain wave activity (eeg), 2-12 hours with health care professional review and report | Facility | 2023 | 14 | 14 | $6,454 | $1,268 | 19.6% |
| 95819 | Measurement of brain wave activity (eeg), awake and asleep | Facility | 2023 | 21 | 22 | $6,182 | $1,086 | 17.6% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Facility | 2023 | 16 | 17 | $5,185 | $831.92 | 16.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 67 | 134 | $47,302 | $13,500 | 28.5% |
| 95720 | Measurement of brain wave activity with video (veeg), 12-26 hours with review and report by health care professional | Facility | 2022 | 31 | 68 | $58,820 | $12,749 | 21.7% |
| 95718 | Measurement of brain wave activity with video (veeg), 2-12 hours with review and report by health care professional | Facility | 2022 | 16 | 18 | $10,062 | $2,187 | 21.7% |
| 95819 | Measurement of brain wave activity (eeg), awake and asleep | Facility | 2022 | 27 | 27 | $7,182 | $1,351 | 18.8% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Facility | 2022 | 15 | 15 | $4,380 | $775.38 | 17.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 71 | 147 | $50,421 | $15,051 | 29.9% |
| 95720 | Continuous measurement of brain wave activity with video (veeg), 12-26 hours, with health care professional analysis, interpretation and report | Facility | 2021 | 48 | 73 | $62,999 | $13,815 | 21.9% |
| 95816 | Measurement and recording of brain wave (eeg) activity, awake and drowsy | Facility | 2021 | 52 | 53 | $14,098 | $2,690 | 19.1% |
| 95718 | Continuous measurement of brain wave activity with video (veeg), 2-12 hours, with health care professional analysis, interpretation and report | Facility | 2021 | 19 | 19 | $10,583 | $2,323 | 22.0% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 17 | 18 | $8,298 | $2,150 | 25.9% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 11 | 11 | $7,150 | $2,132 | 29.8% |
| 95819 | Measurement and recording of brain wave (eeg) activity, awake and asleep | Facility | 2021 | 39 | 39 | $10,374 | $1,883 | 18.2% |
| 95720 | Continuous measurement of brain wave activity with video (veeg), 12-26 hours, with health care professional analysis, interpretation and report | Facility | 2020 | 57 | 109 | $94,067 | $20,947 | 22.3% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 50 | 87 | $31,581 | $6,781 | 21.5% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 26 | 26 | $12,584 | $3,175 | 25.2% |
| 95718 | Continuous measurement of brain wave activity with video (veeg), 2-12 hours, with health care professional analysis, interpretation and report | Facility | 2020 | 19 | 20 | $11,140 | $2,475 | 22.2% |
| 95816 | Measurement and recording of brain wave (eeg) activity, awake and drowsy | Facility | 2020 | 45 | 46 | $12,236 | $2,358 | 19.3% |
| 95819 | Measurement and recording of brain wave (eeg) activity, awake and asleep | Facility | 2020 | 37 | 37 | $9,842 | $1,885 | 19.2% |
| 99354 | Prolonged office or other outpatient service first hour | Office | 2020 | 12 | 12 | $4,512 | $1,431 | 31.7% |
About Dr. Kenneth Laxer, M.D
Dr. Kenneth Laxer, M.D is a Neurology healthcare provider based in San Francisco, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/14/2006. The National Provider Identifier (NPI) number assigned to this provider is 1861460990.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Kenneth Laxer, M.D has received a total of $419,550 in payments from pharmaceutical and medical device companies, with $69,631 received in 2024. These payments were reported across 702 transactions from 34 companies. The most common payment nature is "Honoraria" ($253,575).
As a Medicare-enrolled provider, Laxer has provided services to 838 Medicare beneficiaries, totaling 1,238 services with total Medicare billing of $145,117. Data is available for 4 years (2020–2023), covering 25 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Location San Francisco, CA
- Active Since 03/14/2006
- Last Updated 05/21/2020
- Taxonomy Code 2084N0400X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1861460990
Products in Payments
- XCOPRI (Drug) $273,853
- VNS Therapy (Device) $40,132
- Briviact (Drug) $36,669
- Fycompa (Drug) $27,017
- ONFI (Drug) $13,932
- Cenobamate (Drug) $6,034
- SYMPAZAN (Drug) $4,228
- SABRIL (Drug) $2,059
- TYSABRI (Biological) $1,297
- RNS Neurostimulator Kit (Device) $623.04
- EPIDIOLEX (Drug) $416.33
- RNS System (Device) $300.92
- APTIOM (Drug) $291.81
- ACTIVA (Device) $216.50
- VALTOCO (Drug) $190.06
- Epidiolex (Drug) $160.25
- TROKENDI XR (Drug) $144.16
- Neupro (Drug) $140.89
- Nayzilam (Drug) $125.26
- FYCOMPA (Drug) $113.86
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in San Francisco
Dr. Bruce Cree, M.d, M.D
Neurology — Payments: $609,101
Neurology $609,101
Dr. Scott Zamvil, Md, MD
Neurology — Payments: $591,541
Neurology $591,541
Dr. S Claiborne Johnston, M.d, M.D
Neurology — Payments: $545,407
Neurology $545,407
Dr. Douglas Goodin
Neurology — Payments: $467,336
Neurology $467,336
Dr. Armen Moughamian, Md, MD
Neurology — Payments: $333,078
Neurology $333,078
Nada Hindiyeh
Neurology — Payments: $322,416
Neurology $322,416